Press Releases Guardant Health, Inc.

Equities

GH

US40131M1099

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-14 pm EDT			5-day change	1st Jan Change
24.73 ^USD	+3.04%		+31.40%	-8.58%

May. 10	Guardant Health Shares Rise After Q1 Adjusted Loss Shrinks, Revenue Rises; 2024 Revenue Guidance Raised	MT
May. 09	Earnings Flash (GH) GUARDANT HEALTH Reports Q1 Revenue $168.5M, vs. Street Est of $150.1M	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Guardant Health : Q1 2024 Earnings Call - Presentation	May. 09	PU
Guardant Health: Q1 Earnings Snapshot	May. 09	AQ
Guardant Health Reports First Quarter 2024 Financial Results and Increases 2024 Revenue Guidance	May. 09	BU
Guardant Health to Participate in Upcoming Investor Conferences	May. 07	BU
Guardant Health Surpasses 500 Peer-Reviewed Publications Milestone	May. 07	BU
FDA Advisory Panel Review of Guardant Health's Shield Blood Test to Screen for Colorectal Cancer to Be Held on May 23	Apr. 23	AQ
FDA Advisory Panel Review of Guardant Health’s Shield™ Blood Test to Screen for Colorectal Cancer to Be Held on May 23	Apr. 22	BU
Guardant Health to Report First Quarter 2024 Financial Results on May 9, 2024	Apr. 18	BU
Guardant Health to Present Data Highlighting Application of Epigenomics to Advance Precision Oncology at 2024 AACR Annual Meeting	Apr. 03	BU
Guardant Health - Royal Marsden And Guardant Health Partnership Provides State-of-the-art Blood Test To Benefit Lung Cancer Patients In Expanded NHS Study	Mar. 25	AQ
Blood test shows 83% accuracy for detecting colorectal cancer in trial	Mar. 13	AQ
Guardant Health ECLIPSE Study Data Demonstrating Efficacy of Shield Blood-based Test for Colorectal Cancer Screening to be Published in The New England Journal of Medicine	Mar. 13	BU
Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	Mar. 06	BU
Guardant Health, Inc. - New Survey, Patients and Physicians Overwhelmingly Agree Blood Tests Could Help Close the Colorectal Cancer Screening Gap	Mar. 04	AQ
New Survey: Patients and Physicians Overwhelmingly Agree Blood Tests Could Help Close the Colorectal Cancer Screening Gap	Mar. 01	BU
Guardant Health: Q4 Earnings Snapshot	Feb. 22	AQ
Guardant Health Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Outlook	Feb. 22	BU
Guardant Health to Participate in Upcoming Investor Conferences	Feb. 15	BU
Guardant Health to Report Fourth Quarter and Full Year 2023 Financial Results on February 22, 2024	Feb. 01	BU
Guardant Health to present data at ASCO GI supporting use of liquid biopsy to predict colon cancer recurrence	Jan. 17	BU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Guardant Health, Inc.

Equities

GH

US40131M1099

Press Releases

Filters